Effect of low dose aspirin and dipyridamole on primary patency of arteriovenous grafts in hemodialysis patients: a randomized double-blind placebo-controlled trial

BACKGROUND: There is some evidence for the efficacy of antiplatelet therapies in increasing the vascular access patency duration or decreasing the thrombosis of arteriovenous grafts. OBJECTIVE: To determine the effect of low dose aspirin and dipyridamole on primary patency of arteriovenous grafts in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayebi, Pouya, Kazemzadeh, Gholamhosein, Banihashem, Azin, Ravari, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Electronic physician 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853985/
https://www.ncbi.nlm.nih.gov/pubmed/29588811
http://dx.doi.org/10.19082/6135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853985/
https://www.ncbi.nlm.nih.gov/pubmed/29588811
http://dx.doi.org/10.19082/6135

Ejemplares similares